scispace - formally typeset
T

Tomas Novak

Researcher at Charles University in Prague

Publications -  121
Citations -  4242

Tomas Novak is an academic researcher from Charles University in Prague. The author has contributed to research in topics: Bipolar disorder & Transcranial magnetic stimulation. The author has an hindex of 30, co-authored 120 publications receiving 3630 citations. Previous affiliations of Tomas Novak include National Institutes of Health & Eli Lilly and Company.

Papers
More filters
Journal ArticleDOI

Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) Report

Mirko Manchia, +104 more
TL;DR: The key phenotypic measures of the “Retrospective Criteria of Long-Term Treatment Response in Research Subjects with Bipolar Disorder” scale currently used in the Consortium on lithium Genetics (ConLiGen) study are reported.
Journal ArticleDOI

Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study

Liping Hou, +136 more
- 12 Mar 2016 - 
TL;DR: A genome-wide association study of lithium response in 2,563 patients collected by 22 participating sites from the International Consortium on Lithium Genetics (ConLiGen); the largest attempted so far finds a single locus of four linked SNPs on chromosome 21 met genome- wide significance criteria for association with lithium response.
Journal ArticleDOI

Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder.

Liping Hou, +148 more
TL;DR: A two-stage meta-analysis of GWAS of bipolar disorder patients and controls revealed genome-wide significant associations at two novel loci, adding to a growing list of common autosomal variants involved in BD and illustrating the power of comparing well-characterized cases to an excess of controls in GWAS.
Journal Article

Relationship of ketamine's antidepressant and psychotomimetic effects in unipolar depression.

TL;DR: A substantial relationship between ketamine's antidepressant and psychotomimetic effects was found, and this relationship could be mediated by the initial steps of ketamine’s action, trough NMDA receptors, shared by both ketamines' clinical effects.
Journal ArticleDOI

Increase in GSK3β gene copy number variation in bipolar disorder

TL;DR: Patients with BD have an increased frequency of this CNV—primarily the duplication variant—compared with controls, which suggests that GSK3β may be involved in BD susceptibility in some individuals and that CNVs in this and other candidate genes for psychiatric disorders should be analyzed as causative functional genetic variants.